RadNet reports record Q2 revenue $403.7M, up 13.9% YoY; appoints Dr. Gregory Sorensen as EVP Chief Science Officer

RadNet, Inc.

2023-Q2 EPS reported -$0.21 revenue$794,279,000

Imaging Center segment revenue $401.3M (+13.8% YoY); consolidated revenue $403.7M (+13.9%).
Adjusted EBITDA (incl. AI losses) $60.4M (+17.7% YoY); segment adjusted EBITDA $63.7M (+14.7%).
Same-center procedural volume up 7.1%; aggregate volume up 11.4%.
Raised 2023 imaging center revenue guidance to $1.575-1.610B and Adjusted EBITDA to $232-242M; lowered AI guidance.
Appointed Dr. Gregory Sorensen (CEO of DeepHealth) to Board and as EVP Chief Science Officer; effective Aug 8, 2023.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Gregory Sorensen

Executive Vice President and Chief Science Officer

RDNT · RadNet, Inc.

Effective: 2023-08-08
Filed: August 9, 2023, 7:59 PM ET

On August 4, 2023, the Company appointed Dr. Gregory Sorensen, M.D. (“Dr. Sorensen”) to the Board of Directors (the “Board”) and to serve as the Company’s Executive Vice President and Chief Science Officer, with such appointment effective August 8, 2023.

Appointed

Dr. Gregory Sorensen

Director

RDNT · RadNet, Inc.

Effective: 2023-08-08
Filed: August 9, 2023, 7:59 PM ET

On August 4, 2023, the Company appointed Dr. Gregory Sorensen, M.D. (“Dr. Sorensen”) to the Board of Directors (the “Board”) and to serve as the Company’s Executive Vice President and Chief Science Officer, with such appointment effective August 8, 2023.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

RadNet, Inc. reported financial results for second quarter ended June 30, 2023.

Period: second quarter ended June 30, 2023
Result: reported results

Exact text from the filing

On August 8, 2023 RadNet, Inc. (the “Company”) issued a press release and held a conference call regarding its 2023 financial results for the second quarter ended June 30, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Gregory Sorensen was appointed as Executive Vice President and Chief Science Officer at RadNet, Inc..

Action: appointed
Role: Executive Vice President and Chief Science Officer

Exact text from the filing

On August 4, 2023, the Company appointed Dr. Gregory Sorensen, M.D. (“Dr. Sorensen”) to the Board of Directors (the “Board”) and to serve as the Company’s Executive Vice President and Chief Science Officer, with such appointment effective August 8, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Gregory Sorensen was appointed as Director at RadNet, Inc..

Action: appointed
Role: Director

Exact text from the filing

On August 4, 2023, the Company appointed Dr. Gregory Sorensen, M.D. (“Dr. Sorensen”) to the Board of Directors (the “Board”) and to serve as the Company’s Executive Vice President and Chief Science Officer, with such appointment effective August 8, 2023.

View on SEC.gov

Browse all earnings releases →

RadNet, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-005434

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.